Neural imaging—maps of brain functions—is a primary tool used by researchers hoping to transform the lives of people living with chronic neurological conditions such as epilepsy. At present, researchers often require several different imaging techniques to fully map brain functions, making research and treatment of these conditions expensive and inefficient.
Using cutting-edge illumination technology, Prof. Ofer Levi and his research students from the Institute of Biomaterials & Biomedical Engineering (IBBME) and The Edward S. Rogers Sr. Department of Electrical & Computer Engineering (ECE) at the Univ. of Toronto has developed a new cost-effective neural imaging system. It allows researchers to make much more complex maps of the brain with just one camera and one imaging system. The team's initial findings, released this week in Biomedical Optics Express, demonstrate that this new technology may one day transform the way researchers view the human brain.
Developed from the same technology that lights up our cell phones and computers, this unique system uses Vertical Cavity Surface Emitting Lasers (VCSEL): low-cost, easily-tested, miniature microchip lasers mounted on an extremely fast, sensitive camera, which allows the operator to switch the lasers on and off with extraordinary speed and precision. This rapid light manipulation (at a rate of approximately 1x/millisecond) means that the brain can be mapped with greater sophistication and precision—much more quickly. Results published in Levi's article, for instance, demonstrate that this imaging technology is able to classify both veins and arteries simultaneously—something never before accomplished. . .View Full Article
"INO's stock could hit double digits pretty easily, in terms of its trading range, with a good outcome from the Phase 2 VGX-3100 study." (6/26/14) Inovio Pharmaceuticals Inc. - The Life Sciences Report Interview with Charles Duncan More >
Technology Improves Neural Imaging, Human Brain Research
Source: Laboratory Equipment (4/2/12)
"A new cost-effective neural imaging system allows researchers to make much more complex maps of the brain with just one camera and one imaging system."
"CYTX believes it has hit the points on the checklist to move to the next option of the Celution BARDA study, which could be worth up to $35M." (6/5/14) Cytori Therapeutics Inc. - The Life Sciences Report Interview with Joseph Pantginis More >
"Preeclampsia is a very exciting indication, and PSTI has the potential to completely change how we treat this insidious disease." (6/4/14) Pluristem Therapeutics Inc. - The Life Sciences Report Interview with Jason Kolbert More >